Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04732806 · ClinicalTrials.gov registry record · NA
A Mightier Healthcare System
A NA study of Emotional Dysregulation, sponsored by Neuromotion Labs.
- Completed
- Registry status
- NA
- Development phase
- 183
- Enrollment target
- 1
- Study location
NCT04732806 is a NA study of Emotional Dysregulation that has completed, run by Neuromotion Labs. The registered enrollment target is 183 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04732806, a NA study of Emotional Dysregulation, has completed, sponsored by Neuromotion Labs.
- COMPLETED
- Registry status
- NA
- Development phase
- 183 participants
- Enrollment target
- 1
- Study location
Study Summary
Access to effective pediatric mental health treatment is a major public health concern in the United States as paucity of pediatric providers leading to long wait times, financial burden, and stigma pose significant barriers to treatment. Digital mental health promises to remedy many chronic problems faced in providing timely and accessible mental health interventions to children. With that in mind, the investigators and Neuromotion Inc. created Mightier, an app-based heart rate biofeedback videogame platform designed to teach and facilitate practice of emotional regulation skills. The technology behind Mightier is backed by three trials showing clinical efficacy and since commercial launch 75% of families who have engaged with the product report improvement. However, Neuromotion's core mission remains increasing access to care, and the direct-to-consumer distribution of digital health also faces access challenges. The investigators propose that access to effective digital mental health interventions can be increased by meeting families where they already know to seek care: the traditional healthcare system. The investigators have partnered with a nationwide behavioral health insurance provider to pilot the integration of Mightier with traditional healthcare. Families will be recruited via direct outreach, social media, or healthcare provider referral. Participating children will be randomized into Mightier or treatment as usual control groups for 6 months. Behavioral healthcare utilization will be observed for 12 months. Through this work the investigators will demonstrate the value of Mightier to various stakeholders via decreased long-term healthcare utilization, confirm that Mightier use results in decreased symptoms of emotional dysregulation, irritability, and parent stress, and explore relationships among Mightier use, healthcare utilization, and symptoms. Ultimately this work will pave the way forward for large scale integration of digital healthcare and mor
Conditions Studied
Interventions
- BEHAVIORAL Mightier video games
Study Locations (1)
Massachusetts
- Neuromotion Inc - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2021-03-10 |
| Est. Completion | 2025-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04732806
The ClinicalTrials.gov registry entry for NCT04732806 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 183 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neuromotion Labs, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Emotional Dysregulation appearing as the primary indexed condition, and to 1 intervention - of which Mightier video games is the first listed.
NCT04732806 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04732806 about?
NCT04732806 is a clinical study titled "A Mightier Healthcare System". Access to effective pediatric mental health treatment is a major public health concern in the United States as paucity of pediatric providers leading to long wait times, financial burden, and stigma pose significant barriers to treatment. Digital mental health promises to remedy many chronic problem...
What is the current status of trial NCT04732806?
This trial is currently completed. It is a NA study. The enrollment target is 183 participants. The study started on 2021-03-10. Estimated completion is 2025-10-01.
What conditions does trial NCT04732806 study?
This clinical trial studies the following conditions: Emotional Dysregulation.
What interventions are being tested in trial NCT04732806?
The interventions under investigation include: Mightier video games (BEHAVIORAL).
Who is sponsoring clinical trial NCT04732806?
This trial is sponsored by Neuromotion Labs, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04732806 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Emotional Dysregulation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.